VRTX
$397.27
Revenue | $2771.9Mn |
Net Profits | $1045.4Mn |
Net Profit Margins | 37.71% |
Vertex Pharmaceuticals Incorporated’s revenue jumped 11.61% since last year same period to $2771.9Mn in the Q3 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 5.21% jump in its revenue since last 3-months.
Vertex Pharmaceuticals Incorporated’s net profit jumped 0.98% since last year same period to $1045.4Mn in the Q3 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 129.09% jump in its net profits since last 3-months.
Vertex Pharmaceuticals Incorporated’s net profit margin fell -9.53% since last year same period to 37.71% in the Q3 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 127.65% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 4.14 |
EPS Estimate Current Year | 4.14 |
Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current quarter stand at 4.14 - a 40.82% jump from last quarter’s estimates.
Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current year stand at 4.14.
Earning Per Share (EPS) | 4.38 |
Vertex Pharmaceuticals Incorporated’s earning per share (EPS) jumped 7.35% since last year same period to 4.38 in the Q3 2024. This indicates that the Vertex Pharmaceuticals Incorporated has generated 7.35% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-07 | 4.06 | 4.76 | 17.24% |
2024-11-05 | 4.14 | 4.38 | 5.8% |
2024-08-02 | 2.94 | -12.83 | -536.39% |